loader image
Sunday, February 23, 2025
46.3 F
McAllen
We Welcome your Press Release
- Advertisement -

Rep. Cuellar, City of Laredo to Announce New CDC Office in Laredo for Zika Virus Detection and Response

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Laredo office will focus on increasing Zika surveillance, prevention and preparation on U.S.-Mexico border from Laredo to Brownsville

 LAREDO, Texas – Congressman Henry Cuellar (D-TX-28) and the City of Laredo Health Department on Tuesday will announce the creation of a new office of the Centers for Disease Control and Prevention (CDC) in Laredo, with three CDC-contracted public health professionals. At the request of Congressman Cuellar, the CDC-contracted health professionals will be stationed in Laredo for one year and will work with health professionals from Laredo to Brownsville to focus on increasing surveillance, prevention, preparation and education to combat the Zika virus. No cases of Zika have been reported in Laredo or Webb County at this time.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

UPDATE: Measles Outbreak

Mega Doctor News Mega Doctor News  As of February 18, 2025, the Texas...

DHR Health Celebrates 100th Ion Robotic-Assisted Bronchoscopy

DHR Health, a leader in healthcare serving the Rio Grande Valley, announced today that Dr. Federico Vallejo, pulmonologist, has successfully performed his 100th Ion robotic-assisted bronchoscopy.

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.
- Advertisement -
×